Los Angeles, California 90032

  • Traumatic Stress


This study plans to develop an integrated treatment for comorbid post-traumatic stress disorder (PTSD) and substance abuse (SA) in adolescents. The investigators aim to develop a treatment approach that is community-friendly, well-tolerated, and deliverable by substance abuse counselors (SAC) in outpatient settings. The proposed Trauma-Focused Substance Abuse Treatment (TFSAT) aims to reduce PTSD symptoms and substance use and build coping skills. The investigators propose to adapt an evidence-based trauma program, Cognitive-Behavioral Intervention for Trauma in Schools (CBITS), for adolescent substance abusers (ASAbusers); to assess the acceptability and feasibility of the integrated approach; and to pilot test the new program against standard care. The investigators hypothesize that the intervention group, compared to the control group, will reduce substance use and symptoms for traumatic stress.


Inclusion Criteria: Youth - Between ages of 13 & 19; - meeting DSM IV criteria for substance abuse/dependence and PTSD; - previously enrolled at recruitment site for at least 2 weeks; - parent/guardian provides permission for minors to participate. Exclusion Criteria: Youth - Not within the specified age range; - presence of organic brain damage; - inability to understand enrollment forms (e.g. Informed Assent/Consent Form) Inclusion Criteria: Parents/Guardians - Age 18 or above; - parents/guardians of youth who meets inclusion criteria. Exclusion Criteria: Parents/Guardians - presence of organic brain damage.



Primary Contact:

Principal Investigator
Nancy S Wu, MD
University of California, Los Angeles

Nancy S Wu, MD
Phone: 310-794-0268
Email: nswu@mednet.ucla.edu

Backup Contact:

Email: kmattes@mednet.ucla.edu
Kathy Mattes, BA
Phone: 310-794-2509

Location Contact:

Los Angeles, California 90032
United States

Nancy S Wu, MD
Phone: 310-794-0268
Email: nswu@mednet.ucla.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: September 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.